ResearcherUniversity of TsukubaActive in the last 2 years
Tomoaki Furuta
Matched on ORCID iD 0000-0001-8843-9605; OpenAlex author ID A5054732606. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 6
- Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2026.07.004↗
- Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. Co-author DOI 10.1155/2024/1529449↗
- Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. Co-author DOI 10.1002/ijc.34362↗
- Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models. First author DOI 10.1016/j.bbrc.2020.11.087↗
- Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1111/cas.15023↗
- Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. Co-author DOI 10.1159/000513430↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Oda · 6 shared papers, 2020–2026 · strength 1.00
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Osamu Shimomura · 6 shared papers, 2020–2026 · strength 1.00
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Yoshihiro Miyazaki · 5 shared papers, 2020–2026 · strength 0.84
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Hiroaki Tateno · 5 shared papers, 2020–2024 · strength 0.75
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Paper Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xeno… DOI 10.1016/j.bbrc.2020.11.087↗
- Yoshimasa Akashi · 4 shared papers, 2021–2026 · strength 0.73
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Hiromitsu Nakahashi · 3 shared papers, 2023–2026 · strength 0.61
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Yukihito Kuroda · 3 shared papers, 2020–2024 · strength 0.47
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Paper Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin. DOI 10.1159/000513430↗
- Takahito Nakajima · 2 shared papers, 2023–2026 · strength 0.41
- Shuntaro Tsukamoto · 1 shared paper, 2026 · strength 0.25
- Kentaro Hatano · 1 shared paper, 2026 · strength 0.25
- Sota Kimura · 2 shared papers, 2020–2021 · strength 0.23
- Kayo Hasehira · 1 shared paper, 2021 · strength 0.16
- Tsuyoshi Enomoto · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.